DO GOOD
BY PEOPLE
AND PLANET
We have a scalable way forward in a world where the supply of natural resources falls short of global demand.
LEARN MORE ABOUT OUR NO COMPROMISE® PLEDGELeaders in synthetic biology, we started back in 2003 with a grant from the Bill & Melinda Gates Foundation to create a molecule to treat malaria. By engineering the genetics of yeast strains and fermenting them in sugarcane syrup, we pioneered the ability to convert basic plant sugars to hydrocarbon molecules. To date, we have successfully created and commercialized a total of 13 sustainable ingredients that are used by hundreds of millions of people, in products made by more than 3,000 top global brands.
In 2020, we manufactured and sold more bio-based sustainable products from fermentation than all of the companies in our sector. This is our clean advantage and one of the reasons companies including DSM, Ingredion, Firmenich, Givaudan, L’Oreal, Shiseido, Natura, Estee Lauder, Sumitomo and many others partner with us. We help companies transform their supply chains, lower their costs and meet the needs of their customers for sustainable products.
With our leading Lab-to-Market™ platform, clean manufacturing and our award-winning product development and formulation team, we have also successfully built our own portfolio of sustainable consumer brands that are winning new loyalists every day. The future of health, wellness and beauty is clean chemistry, and we are leading the way with our own consumer brands and our partners. This is our winning business model.
Our mission to shift the world to sustainable ingredients will lead to other global shifts— from scarcity to abundance, privilege to right, dependence to autonomy. That’s why we pursue what’s difficult, work at warp speed and set the bar so high.
At Amyris, we aim big and broad, creating prosperity for people, the planet, and business. So that we can continue to deliver on the promise of synthetic biology and make a lasting impact.
OUR
CORE
VALUES
Collaboration
We work with each other, our partners, our customers and biology to achieve exceptional results. We value, respect and learn from each other as we strive for mutual success.
Amyrous
We love what we do and love what we make. We are passionate about having a positive impact. We have fun, keep a sense of humor and enjoy working together.
Innovation
We continuously solve unsolved needs. We are driven to accomplish the seemingly impossible. We embrace intelligent risk and are a learning organization.
Safety
We demonstrate a deep regard for the safety and well-being of our people, our communities, our resources and our planet. We speak up courageously.
Integrity
We are honest, fair and ethical. We hold ourselves accountable and deliver on our commitments. We do what we say.
OUR HISTORY
- Amyris’ inaugural ESG report
- Broke ground on new manufacturing plant in Brazil.
- Acquired several consumer brands to address niche markets of clean beauty
- Announced strategic deals with Ingredion and DSM for ingredient distribution
- Reese Witherspoon joined Biossance as brand ambassador
- Achieved Bonsucro certification
- Pipette rapidly scales hand sanitizer production for frontline healthcare workers
- Partnered with the Infectious Disease Research Institute for novel RNA vaccine platform
- Formed R&D partnership with Universidade Católica Portuguesa and AICEP
- Commercialization of Reb M sweetener molecule
- Partnered with Firmenich on new fragrance molecule
- Launched Biossance
- Formed joint venture with Nikkol Group for cosmetic ingredients
- Partnered with Givaudan on cosmetic active molecule
- Partnered with DSM on human nutrition molecule
- Partnered with International Flavors and Fragrances on fragrance molecules
- Large-scale production of Amyris’ artemisinin by Sanofi
- Established manufacturing capability at Brotas 1 in Brazil
- Partnered with DARPA for multiple fermentation molecules
- Completed large-scale production of squalane with Soliance SA
- Partnered with Firmenich on three flavor and fragrance ingredients
- Achieved Bonsucro certification
- Pipette rapidly scales hand sanitizer production for frontline healthcare workers
- Partnered with the Infectious Disease Research Institute for novel RNA vaccine platform
- Formed R&D partnership with Universidade Católica Portuguesa and AICEP
- Commercialization of Reb M sweetener molecule
- Partnered with Firmenich on new fragrance molecule
- Partnered with International Flavors and Fragrances on fragrance molecules
- Large-scale production of Amyris’ artemisinin by Sanofi
- Completed large-scale production of squalane with Soliance SA
- Partnered with Firmenich on three flavor and fragrance ingredients
- Received grant from the Bill and Melinda Gates Foundation to develop the artemisinin molecule used to treat malaria